含雷公藤红素润肤膏作为银屑病辅助护理的耐受性与疗效
这项研究评估含雷公藤红素的新型润肤膏在银屑病患者中的耐受性及单独使用时的疗效。结果显示未报告产品相关反应,耐受性极佳;单用组瘙痒强度评分在D8和D29分别较D1显著下降39%和60%(P<0.001),全身病变评分分别下降24%和26%(P<0.001),生活质量改善,化妆品可接受性良好。
要点
- 含雷公藤红素润肤膏全身使用4周耐受性极佳,无产品相关反应报告
- 单用润肤膏可显著改善瘙痒,D29较D1下降60%
- 单用润肤膏可显著改善全身病变评分,D29较D1下降26%
核心结论
- 含雷公藤红素的新型润肤膏在躯干斑块状银屑病患者中单独或联合药物治疗或光疗均耐受性良好。
- 每日使用一个月可改善瘙痒、体征和生活质量。
研究设计与样本
- 成人躯干斑块状银屑病患者每日全身涂抹含雷公藤红素润肤膏一次,共4周。
- 单用润肤膏组41例,联用现有治疗组50例。
- 在D1、D8(单用研究)或D15(联用研究)及D29由皮肤科医生评估体征和症状。
主要发现
- 未报告产品相关反应,耐受性判定为极佳。
- 单用研究中,平均瘙痒强度评分D8较D1下降39%(P<0.001),D29下降60%(P<0.001)。
- 单用研究中,全身病变评分D8下降24%,D29下降26%(P<0.001)。
- 患者报告结局问卷显示生活质量改善。
- 化妆品可接受性良好。
关键数值与推荐
- 单用组瘙痒强度评分D8较D1下降39%(P<0.001),D29下降60%(P<0.001)。
- 单用组全身病变评分D8下降24%,D29下降26%(P<0.001)。
临床怎么用
- 含雷公藤红素润肤膏可作为躯干斑块状银屑病的辅助护理,单独或联合药物/光疗使用。
- 每日全身涂抹一次可能有助于改善瘙痒和皮肤体征,并提高长期依从性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with psoriasis, the non-lesional skin also presents abnormalities, requiring emollient application on the whole body. OBJECTIVES: To evaluate the tolerance of a new emollient balm containing celastrol, an active ingredient with anti-Th17 immunomodulatory properties used alone or in association with topical or systemic drug treatments or phototherapy, and its efficacy when used alone. METHODS: Adults with body plaque psoriasis applied the product over the whole body once a day for 4 weeks (balm used alone in 41 patients and with ongoing treatment in 50 patients). At D1, D8 ('balm alone' study) or D15 ('balm in association' study) and D29, the dermatologist rated physical and functional signs and assessed pruritus and body global lesion score (evaluating erythema, induration/thickness, scaling and dryness) in the 'balm alone' study. RESULTS: No reaction related to the product was reported, and the tolerance was deemed excellent. In the 'balm alone' study, mean pruritus intensity score significantly decreased at D8 (-39%, P < 0.001) and D29 (-60%, P < 0.001) compared with D1, together with the body global lesion score (-24% at D8 and -26% at D29, P < 0.001). In parallel, quality of life improved, as evidenced by a patient-reported outcome questionnaire. Cosmetic acceptability was good. CONCLUSION: This new emollient balm was very well tolerated by patients with body plaque psoriasis either alone or in association with drug treatment or phototherapy, which is important to ensure long-term compliance. Daily application during one month improved pruritus, physical signs and quality of life.
引用
- Thouvenin MD, Dalmon S, Theunis J, et al. Tolerance and efficacy of a new celastrol-containing balm as adjunct care in psoriasis. J Eur Acad Dermatol Venereol. 2020. PMID: 32783264. doi:10.1111/jdv.16691
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。